Skye Bioscience, Inc. (SKYE)
0.75
-0.03
(-3.85%)
USD |
NASDAQ |
Dec 30, 09:33
Skye Bioscience Total Liabilities (Quarterly): 8.488M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 52.61M |
| Theravance Biopharma, Inc. | 182.78M |
| Viking Therapeutics, Inc. | 26.38M |
| FibroGen, Inc. | 119.53M |
| Myomo, Inc. | 19.45M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 41.32M |
| Shareholders Equity (Quarterly) | 32.84M |
| Debt to Equity Ratio | 0.0098 |
| Current Ratio | 4.771 |
| Net Debt Paydown Yield | 0.78% |